Abbott Launches World's First Pivotal Trial to Test New Approach for Repairing Leaky Tricuspid Heart Valves
- TRILUMINATE Pivotal trial is the world's first randomized clinical trial to evaluate transcatheter tricuspid valve repair in patients with severe tricuspid regurgitation
Source: Abbott.com - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Clinical Trials | Gastroschisis Repair | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Pharmaceuticals